Syndax Pharmaceuticals
World Rank (Jan-05-2024)
6,088
Market Cap (Jan-05-2024)
1.788 Billion USD
World Rank (Jul-30-2023)
6,989
Market Cap (Jul-30-2023)
1.461 Billion USD
World Rank (Dec-25-2022)
6,132
Market Cap (Dec-25-2022)
1.655 Billion USD
World Rank (Jan-07-2022)
9,280
Market Cap (Jan-07-2022)
1.03 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-149 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Syndax Pharmaceuticals is a Clinical Stage Biopharmaceutical company developing an innovative pipeline of cancer therapies. The company annual revenue is 1.5 million USD and 38 employees as on 2019. The headquarters is in USA.
Company Website